Alternate Methodology of Pulse Oximeter Validation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-26

Study Completion Date

2023-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will determine if the replacement of the measured arterial blood oxygen saturation with expired (end-tidal) oxygen value is an acceptable method to calculate the accuracy of pulse oximeters.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Accuracy Validation of a Pulse Oximetry Monitor

NCT02506010

Healthy

WITHDRAWN

Pulse Oximeter Accuracy in Healthy Humans During Hypoxia

NCT06142019

Hypoxia Skin Pigmentation

RECRUITING

Accuracy of Pulse Oximeters With Profound Hypoxia

NCT02571686

Oximetry, Pulse

COMPLETED

Pulse Oximeter Hypoxia

NCT04562584

Oximetry

COMPLETED NA

Imputation of Arterial Oxygen Partial Pressures Using Pulse Oximetry

NCT06283914

Oxygen Saturation Respiratory Distress Syndrome Anesthesia, General

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pulse oximeters are non-invasive devices that use light to display an estimate (denoted by SpO2) of the true arterial blood oxygen saturation (SaO2). The accuracy of the pulse oximeter is determined from desaturation sequences (reduction in SpO2 from 100 to 70%) performed in healthy volunteers. The current standard desaturation sequence is a step-wise reduction in 5% SpO2 increments, achieved by reduction in inspired oxygen delivered by a gas blender such as the ROBD (Reduced Oxygen Breathing Device). This mixes oxygen and nitrogen (components of air) to produce the desired gas mixture. Throughout the desaturation sequence arterial blood gas samples are drawn at each step. The blood gas samples are processed through a co-oximeter to measure the SaO2. For each SaO2 measurement there will be a corresponding SpO2 recorded. All data points from all subjects are amalgamated together to allow calculation of how well SpO2 corresponds to the SaO2 throughout the range of 70 - 100% oxygen saturation. Accuracy, A\[RMS\], is the unit of measure and this incorporates both bias and precision.

When the ROBD is used in a desaturation sequence, the subjects' arterial blood carbon dioxide (CO2) level will initially be normal (normocapnia). With the reduction in SpO2 during the desaturation sequence, the subjects' breathing rate will increase and this will cause the a physiological reduction in the blood CO2 value (hypocapnia). The extent of hypocapnia will vary from one subject to another. It is not known whether the presence of hypocapnia may have an effect upon the accuracy measurement.

The RespirAct is a gas blender which, in contrast to the ROBD, can control both the oxygen level as well as the carbon dioxide level. The end-tidal oxygen level (PAO2) is continuously displayed by the RespirAct during the desaturation sequence. The PAO2 closely approximates to arterial blood oxygen (PaO2) - the degree of closeness will be measured in the study. Through an accepted formula, the SaO2 can be derived from the measured PAO2. The derived SaO2 values can subsequently be used to measure the accuracy of the pulse oximeter. This A\[RMS\] can then be compared with the A\[RMS\] calculated from the blood gas co-oximeter PaO2 / SaO2 values. If the accuracies are comparable then this would remove the need for arterial line placement during pulse oximeter validation studies.

Eligible healthy volunteers will complete five (5) oxygen desaturation sequences with adjustment of sequence type and/or CO2 level. Two sequences will be delivered by step-wise reduction and two will be delivered by gradual slope. Two sequences will be delivered at normocapnia and two will be delivered at hypocapnia values. The ROBD sequence will be a step-wise reduction with CO2 value set by the subjects' own breathing control.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoxemia Desaturation of Blood

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RespirAct Step-Wise Normocapnia desaturation sequence

Reduction in oxygen saturation 100 to 70% in approximate 5% steps.

Group Type EXPERIMENTAL

RespirAct Step-Wise Normocapnia desaturation sequence

Intervention Type DEVICE

Blood carbon dioxide controlled at normal value (normocapnia).

RespirAct Slope Normocapnia desaturation sequence

Reduction in oxygen saturation 100 to 70% as gradual slope.

Group Type EXPERIMENTAL

RespirAct Slope Normocapnia desaturation sequence

Intervention Type DEVICE

Blood carbon dioxide controlled at normal value (normocapnia).

RespirAct Step-Wise Hypocapnia desaturation sequence

Reduction in oxygen saturation 100 to 70% in approximate 5% steps.

Group Type EXPERIMENTAL

RespirAct Step-Wise Hypocapnia desaturation sequence

Intervention Type DEVICE

Blood carbon dioxide controlled at lower than normal value (hypocapnia).

RespirAct Slope Hypocapnia desaturation sequence

Reduction in oxygen saturation 100 to 70% as gradual slope.

Group Type EXPERIMENTAL

RespirAct Slope Hypocapnia desaturation sequence

Intervention Type DEVICE

Blood carbon dioxide controlled at lower than normal value (hypocapnia).

ROBD Step-Wise desaturation sequence

ROBD = Reduced Oxygen Breathing Device. Reduction in oxygen saturation 100 to 70% in approximate 5% steps. This represents the standard type of desaturation sequence for pulse oximeter accuracy testing.

Group Type ACTIVE_COMPARATOR

ROBD Step-Wise desaturation sequence

Intervention Type DEVICE

Blood carbon dioxide is controlled at normal or lower value by subject's own breathing rate.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RespirAct Step-Wise Normocapnia desaturation sequence

Blood carbon dioxide controlled at normal value (normocapnia).

Intervention Type DEVICE

RespirAct Slope Normocapnia desaturation sequence

Blood carbon dioxide controlled at normal value (normocapnia).

Intervention Type DEVICE

RespirAct Step-Wise Hypocapnia desaturation sequence

Blood carbon dioxide controlled at lower than normal value (hypocapnia).

Intervention Type DEVICE

RespirAct Slope Hypocapnia desaturation sequence

Blood carbon dioxide controlled at lower than normal value (hypocapnia).

Intervention Type DEVICE

ROBD Step-Wise desaturation sequence

Blood carbon dioxide is controlled at normal or lower value by subject's own breathing rate.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 - 50 years
* Subject is willing to provide written informed consent and is able to comply with anticipated study procedures

Exclusion Criteria

* Body Mass Index (BMI) \< 18.0 or \> 30.0
* Known significant respiratory, cardiovascular or medical condition that precludes study participation as judged by investigator
* Anemia \[hemoglobin value below lower range of normal for gender\]
* Abnormal hemoglobin electrophoresis result
* Exposure to nicotine \[positive test at screening or study day\]
* Abnormal drug screen \[positive test at screening or on day of study\]
* Positive pregnancy test for females \[serum test at screening; urine test on study day\]
* Abnormal Allen's test for collateral circulation
* Abnormal Electrocardiogram
* Abnormal Pulmonary Function Test
* Abnormal venous blood gas result
* Intolerance of facemask

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes